What is the Clinical Pulmonary Infection Score (CPIS), how is it calculated, and when should it be used?

What is CPIS?

The Clinical Pulmonary Infection Score (CPIS) is a semi-objective diagnostic tool that combines clinical, radiographic, physiological, and microbiological parameters to assess the likelihood of ventilator-associated pneumonia (VAP), but it has significant limitations in diagnostic accuracy and should NOT be used alone to decide whether to initiate or withhold antibiotics. 1, 2

Components of CPIS Calculation

The CPIS is calculated based on six variables, each assigned points to create a score ranging from 0 to 12 3:

The Six Variables:

• Temperature (fever assessment)
• White blood cell count (leukocytosis or leukopenia)
• Volume and purulence of tracheal secretions
• Oxygenation (PaO₂/FiO₂ ratio)
• Chest radiograph findings (presence and character of infiltrates)
• Semi-quantitative culture of tracheal aspirate (presence and predominance of organisms on Gram stain)

Scoring Threshold:

• CPIS >6 traditionally suggests higher likelihood of VAP
• CPIS ≤6 suggests lower probability of pneumonia 1

When to Use CPIS (and Critical Limitations)

Current Guideline Recommendations:

The 2016 IDSA/ATS guidelines explicitly recommend AGAINST using CPIS to decide whether to initiate antibiotics 2. The panel found that CPIS has:

• Sensitivity: 65% (misses 35% of VAP cases)
• Specificity: 64% (falsely identifies 36% of non-VAP as VAP)
• Poor diagnostic accuracy with area under the curve of only 0.748 2

Where CPIS May Have Limited Utility:

1. Serial Monitoring for Antibiotic De-escalation:

• Calculate CPIS on Day 1 when VAP is suspected
• Recalculate on Day 3 (48-72 hours later) 3
• If Day 1 CPIS ≤6 AND Day 3 CPIS ≤6: Consider discontinuing antibiotics in patients without recent antibiotic changes (within 72 hours) 3, 1
• A modified CPIS ≤6 maintained for 3 days may identify low-risk patients for early antibiotic discontinuation 1

2. Monitoring Treatment Response:

• A rising CPIS during treatment correlates with higher mortality and suggests treatment failure 3
• Changes in CPIS may help assess clinical response, though PaO₂/FiO₂ ratio alone may be more predictive 4

3. Research Settings Only:

• CPIS has substantial inter-observer variability (kappa = 0.16), making it unreliable for multi-center trials 5
• Cannot be routinely used as a standardized research tool 4

Critical Pitfalls and Caveats:

Major Limitations:

Diagnostic Accuracy Problems:

• When compared to quantitative BAL cultures (reference standard), CPIS showed sensitivity 83% but specificity only 17% 5
• In validation studies using histology and lung cultures, sensitivity was only 72-77% with specificity 42-85% 3
• Overdiagnoses VAP, leading to unnecessary antibiotic use in 53% of patients without true VAP 6

Clinical Context Matters:

• CPIS has NOT been validated in acute lung injury or trauma patients 4
• The score performs poorly in patients who received antibiotics within 72 hours prior to assessment 3
• Negative predictive value is only reliable when no recent antibiotic changes occurred 1

What to Do Instead:

For Initiating Antibiotics:

• Use clinical criteria alone: new/progressive infiltrate PLUS at least 2 of 3 features (fever >38°C, leukocytosis/leukopenia, purulent secretions) 1
• Start empiric antibiotics immediately after obtaining cultures 3
• Do NOT withhold antibiotics based on low CPIS alone 2

For Stopping Antibiotics:

• Reassess at 48-72 hours with clinical response (temperature, WBC, chest X-ray, oxygenation) 1
• If using non-quantitative cultures: negative cultures + CPIS ≤6 on Days 1 and 3 + no antibiotic changes in prior 72h = consider stopping 3
• If using quantitative cultures: colony count below threshold is more reliable than CPIS for discontinuation decisions 3

The 2017 European guidelines suggest against routine antibiotic treatment beyond 3 days in patients with low CPIS (≤6) and no clinical deterioration within 72 hours 7, but this requires careful clinical judgment and absence of severe sepsis.

Bottom Line:

CPIS is a flawed diagnostic tool that should never replace clinical judgment for starting antibiotics. Its primary utility is as one component of a serial assessment strategy to identify patients who may safely discontinue antibiotics early, and only when combined with culture results and clinical improvement 1, 2.